Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Income Statement
Earnings Waterfall
Beijing Tiantan Biological Products Corp Ltd
Revenue
|
5.2B
CNY
|
Cost of Revenue
|
-2.6B
CNY
|
Gross Profit
|
2.6B
CNY
|
Operating Expenses
|
-911.6m
CNY
|
Operating Income
|
1.7B
CNY
|
Other Expenses
|
-606.3m
CNY
|
Net Income
|
1.1B
CNY
|
Income Statement
Beijing Tiantan Biological Products Corp Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
1 836
N/A
|
1 905
+4%
|
2 018
+6%
|
2 026
+0%
|
1 827
-10%
|
1 723
-6%
|
1 567
-9%
|
1 545
-1%
|
1 618
+5%
|
1 624
+0%
|
1 709
+5%
|
1 756
+3%
|
2 138
+22%
|
2 330
+9%
|
2 256
-3%
|
2 362
+5%
|
2 483
+5%
|
2 485
+0%
|
2 671
+7%
|
2 929
+10%
|
2 931
+0%
|
3 083
+5%
|
3 271
+6%
|
3 394
+4%
|
3 282
-3%
|
3 334
+2%
|
3 276
-2%
|
3 398
+4%
|
3 446
+1%
|
3 535
+3%
|
3 702
+5%
|
3 628
-2%
|
4 112
+13%
|
3 970
-3%
|
4 191
+6%
|
4 207
+0%
|
4 261
+1%
|
4 848
+14%
|
5 062
+4%
|
5 371
+6%
|
5 180
-4%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(809)
|
(831)
|
(897)
|
(895)
|
(818)
|
(781)
|
(733)
|
(734)
|
(910)
|
(877)
|
(916)
|
(917)
|
(1 025)
|
(1 087)
|
(1 033)
|
(1 111)
|
(1 206)
|
(1 251)
|
(1 381)
|
(1 545)
|
(1 548)
|
(1 654)
|
(1 755)
|
(1 800)
|
(1 647)
|
(1 731)
|
(1 694)
|
(1 766)
|
(1 735)
|
(1 812)
|
(1 912)
|
(1 857)
|
(2 159)
|
(2 123)
|
(2 228)
|
(2 251)
|
(2 172)
|
(2 551)
|
(2 639)
|
(2 759)
|
(2 553)
|
|
Gross Profit |
1 027
N/A
|
1 074
+5%
|
1 122
+4%
|
1 132
+1%
|
1 009
-11%
|
942
-7%
|
834
-11%
|
811
-3%
|
708
-13%
|
747
+6%
|
794
+6%
|
840
+6%
|
1 114
+33%
|
1 244
+12%
|
1 223
-2%
|
1 252
+2%
|
1 277
+2%
|
1 234
-3%
|
1 290
+5%
|
1 384
+7%
|
1 383
0%
|
1 430
+3%
|
1 516
+6%
|
1 593
+5%
|
1 635
+3%
|
1 603
-2%
|
1 582
-1%
|
1 633
+3%
|
1 711
+5%
|
1 723
+1%
|
1 790
+4%
|
1 771
-1%
|
1 954
+10%
|
1 847
-5%
|
1 963
+6%
|
1 956
0%
|
2 089
+7%
|
2 297
+10%
|
2 423
+5%
|
2 612
+8%
|
2 628
+1%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(462)
|
(508)
|
(549)
|
(618)
|
(612)
|
(613)
|
(579)
|
(590)
|
(416)
|
(474)
|
(516)
|
(487)
|
(672)
|
(706)
|
(671)
|
(637)
|
(501)
|
(405)
|
(397)
|
(417)
|
(526)
|
(540)
|
(567)
|
(618)
|
(611)
|
(580)
|
(581)
|
(557)
|
(641)
|
(618)
|
(649)
|
(676)
|
(773)
|
(752)
|
(770)
|
(766)
|
(761)
|
(724)
|
(776)
|
(797)
|
(912)
|
|
Selling, General & Administrative |
(429)
|
(474)
|
(525)
|
(566)
|
(495)
|
(554)
|
(526)
|
(488)
|
(267)
|
(405)
|
(400)
|
(446)
|
(485)
|
(644)
|
(640)
|
(590)
|
(383)
|
(343)
|
(320)
|
(331)
|
(403)
|
(426)
|
(459)
|
(489)
|
(476)
|
(467)
|
(466)
|
(480)
|
(521)
|
(524)
|
(550)
|
(560)
|
(611)
|
(617)
|
(626)
|
(629)
|
(631)
|
(659)
|
(715)
|
(725)
|
(735)
|
|
Research & Development |
0
|
0
|
0
|
0
|
(94)
|
0
|
0
|
0
|
(112)
|
0
|
0
|
0
|
(143)
|
0
|
0
|
(14)
|
(84)
|
0
|
0
|
(60)
|
(98)
|
(94)
|
(116)
|
(138)
|
(112)
|
(121)
|
(127)
|
(101)
|
(114)
|
(115)
|
(118)
|
(126)
|
(127)
|
(142)
|
(147)
|
(144)
|
(115)
|
(109)
|
(90)
|
(99)
|
(133)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(36)
|
0
|
0
|
0
|
(40)
|
0
|
0
|
0
|
(38)
|
0
|
0
|
0
|
(32)
|
0
|
0
|
0
|
(29)
|
0
|
0
|
0
|
(26)
|
0
|
0
|
0
|
(43)
|
0
|
0
|
0
|
(49)
|
0
|
0
|
0
|
(62)
|
|
Other Operating Expenses |
(33)
|
(34)
|
(24)
|
(52)
|
(2)
|
(58)
|
(53)
|
(102)
|
(2)
|
(69)
|
(116)
|
(42)
|
(4)
|
(62)
|
(31)
|
(33)
|
4
|
(61)
|
(77)
|
(25)
|
6
|
(20)
|
8
|
9
|
5
|
9
|
11
|
24
|
21
|
21
|
20
|
10
|
8
|
7
|
3
|
7
|
34
|
45
|
28
|
27
|
19
|
|
Operating Income |
565
N/A
|
567
+0%
|
573
+1%
|
513
-10%
|
397
-23%
|
329
-17%
|
256
-22%
|
221
-14%
|
292
+32%
|
273
-6%
|
278
+2%
|
352
+27%
|
442
+26%
|
537
+21%
|
552
+3%
|
615
+11%
|
777
+26%
|
830
+7%
|
893
+8%
|
967
+8%
|
857
-11%
|
890
+4%
|
950
+7%
|
976
+3%
|
1 025
+5%
|
1 023
0%
|
1 001
-2%
|
1 075
+7%
|
1 070
-1%
|
1 105
+3%
|
1 141
+3%
|
1 095
-4%
|
1 181
+8%
|
1 095
-7%
|
1 193
+9%
|
1 190
0%
|
1 328
+12%
|
1 574
+19%
|
1 646
+5%
|
1 815
+10%
|
1 716
-5%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(28)
|
(25)
|
(31)
|
(51)
|
(112)
|
(136)
|
(154)
|
(154)
|
(110)
|
(109)
|
(103)
|
(98)
|
(94)
|
(97)
|
697
|
716
|
(29)
|
772
|
9
|
17
|
12
|
18
|
18
|
22
|
24
|
25
|
27
|
23
|
33
|
32
|
39
|
63
|
78
|
94
|
98
|
91
|
88
|
79
|
81
|
83
|
89
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
792
|
10
|
10
|
(0)
|
0
|
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
0
|
2
|
0
|
6
|
6
|
(14)
|
0
|
0
|
10
|
16
|
0
|
16
|
0
|
(0)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
|
Total Other Income |
10
|
10
|
11
|
3
|
20
|
21
|
17
|
21
|
17
|
17
|
25
|
28
|
22
|
23
|
14
|
8
|
8
|
7
|
11
|
10
|
1
|
(3)
|
(4)
|
(4)
|
(4)
|
(3)
|
(2)
|
(3)
|
1
|
(0)
|
(1)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
(5)
|
|
Pre-Tax Income |
547
N/A
|
551
+1%
|
553
+0%
|
465
-16%
|
304
-35%
|
214
-30%
|
119
-44%
|
87
-27%
|
198
+128%
|
180
-9%
|
199
+10%
|
280
+41%
|
370
+32%
|
463
+25%
|
1 263
+173%
|
1 347
+7%
|
1 547
+15%
|
1 619
+5%
|
922
-43%
|
993
+8%
|
868
-13%
|
904
+4%
|
963
+7%
|
993
+3%
|
1 043
+5%
|
1 045
+0%
|
1 026
-2%
|
1 096
+7%
|
1 105
+1%
|
1 136
+3%
|
1 186
+4%
|
1 162
-2%
|
1 241
+7%
|
1 185
-5%
|
1 287
+9%
|
1 288
+0%
|
1 426
+11%
|
1 648
+16%
|
1 738
+5%
|
1 893
+9%
|
1 799
-5%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(85)
|
(89)
|
(86)
|
(75)
|
(77)
|
(69)
|
(64)
|
(76)
|
(82)
|
(85)
|
(82)
|
(76)
|
(74)
|
(83)
|
(118)
|
(128)
|
(162)
|
(170)
|
(156)
|
(175)
|
(132)
|
(131)
|
(138)
|
(141)
|
(149)
|
(150)
|
(145)
|
(154)
|
(162)
|
(163)
|
(172)
|
(161)
|
(172)
|
(168)
|
(178)
|
(183)
|
(222)
|
(260)
|
(288)
|
(307)
|
(289)
|
|
Income from Continuing Operations |
462
|
463
|
467
|
390
|
226
|
144
|
55
|
11
|
116
|
95
|
117
|
204
|
296
|
380
|
1 145
|
1 220
|
1 385
|
1 449
|
767
|
818
|
736
|
772
|
825
|
852
|
894
|
895
|
880
|
942
|
943
|
973
|
1 014
|
1 001
|
1 069
|
1 017
|
1 109
|
1 104
|
1 205
|
1 388
|
1 450
|
1 587
|
1 509
|
|
Income to Minority Interest |
(89)
|
(92)
|
(90)
|
(99)
|
(98)
|
(99)
|
(101)
|
(99)
|
(106)
|
(98)
|
(62)
|
(53)
|
(39)
|
(67)
|
(106)
|
(143)
|
(212)
|
(221)
|
(234)
|
(250)
|
(226)
|
(242)
|
(262)
|
(273)
|
(283)
|
(284)
|
(279)
|
(301)
|
(304)
|
(314)
|
(321)
|
(301)
|
(309)
|
(284)
|
(301)
|
(302)
|
(324)
|
(371)
|
(387)
|
(419)
|
(400)
|
|
Net Income (Common) |
372
N/A
|
371
0%
|
377
+2%
|
291
-23%
|
128
-56%
|
46
-64%
|
(46)
N/A
|
(88)
-93%
|
10
N/A
|
(3)
N/A
|
55
N/A
|
151
+176%
|
257
+70%
|
313
+22%
|
1 038
+232%
|
1 077
+4%
|
1 173
+9%
|
1 228
+5%
|
532
-57%
|
568
+7%
|
510
-10%
|
531
+4%
|
563
+6%
|
580
+3%
|
611
+5%
|
611
+0%
|
601
-2%
|
641
+7%
|
639
0%
|
659
+3%
|
692
+5%
|
700
+1%
|
760
+9%
|
733
-3%
|
808
+10%
|
803
-1%
|
881
+10%
|
1 018
+16%
|
1 063
+4%
|
1 168
+10%
|
1 110
-5%
|
|
EPS (Diluted) |
0.3
N/A
|
0.3
N/A
|
0.31
+3%
|
0.24
-23%
|
0.1
-58%
|
0.04
-60%
|
-0.04
N/A
|
-0.07
-75%
|
0.01
N/A
|
0
N/A
|
0.07
N/A
|
0.12
+71%
|
0.2
+67%
|
0.24
+20%
|
0.83
+246%
|
0.86
+4%
|
0.94
+9%
|
0.99
+5%
|
0.43
-57%
|
0.45
+5%
|
0.41
-9%
|
0.41
N/A
|
0.44
+7%
|
0.46
+5%
|
0.49
+7%
|
0.49
N/A
|
0.48
-2%
|
0.51
+6%
|
0.51
N/A
|
0.52
+2%
|
0.43
-17%
|
0.41
-5%
|
0.48
+17%
|
0.45
-6%
|
0.34
-24%
|
0.48
+41%
|
0.53
+10%
|
0.61
+15%
|
0.65
+7%
|
0.71
+9%
|
0.67
-6%
|